SLC1A2 and temporal lobe epilepsy: Another strategy to increase EAAT2 levels in vivo is the inhibition of Hsp90, which prevents EAAT2 degradation and suppresses spontaneous recurrent seizures in a mouse model of temporal lobe epilepsy [172].